NEW YORK (GenomeWeb) – Invitae announced today that it has acquired privately owned data company AltaVoice. Under the terms of the deal, Invitae purchased all of AltaVoice's stock in exchange for $5 million in Invitae common stock and up to an additional $10 million in Invitae common stock if certain future milestones are met.

The acquisition will add to Invitae's Genome Network, the company said, which connects patients, clinicians, advocacy organizations, researchers, and pharma companies to advance the understanding of hereditary disease and its possible treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.